Use of a new jumbo forceps improves tissue acquisition of Barrett's esophagus surveillance biopsies
Background
The major risk factors for the development of esophageal adenocarcinoma remain long-standing GERD and resultant Barrett's esophagus (BE). Finding the exact method of adequate tissue sampling for surveillance of dysplasia in BE remains a dilemma.
Objective
We prospectively compared standard large-capacity biopsy forceps with a new jumbo biopsy forceps for dysplasia detection in BE.
Setting/Design
Prospective, single-center investigation.
Patients/Interventions
We prospectively enrolled 32 patients undergoing surveillance endoscopy for BE. Biopsy samples were obtained in paired fashion alternating between the experimental (jumbo) and control (large-capacity) forceps.
Main Outcome Measurements
Each sample was assessed for histopathology, specimen size, and adequacy.
Results
A total of 712 specimens were available for analysis for this investigation. Six patients were found to have dysplasia, and in 5 of those patients, the dysplasia was only detected with the jumbo forceps. The mean width was significantly greater in the Radial Jaw 4 jumbo group (3.3 mm vs 1.9 mm [P < .005]) as was the mean depth (2.0 mm vs 1.1 mm [P < .005]). Sixteen percent of samples obtained with the standard forceps provided an adequate sample, whereas the jumbo forceps provided an adequate sample 79% of the time (P < .05).
Limitations
A lack of a validated index for assessment of tissue adequacy in BE.
Conclusion
The Radial Jaw 4 jumbo biopsy forceps significantly improves dysplasia detection and adequate tissue sampling in patients undergoing endoscopy for BE.
Abbreviations: BE, Barrett's esophagus, DGS, depth grade scale, HGD, high-grade dysplasia, IBD, inflammatory bowel disease, LGD, low-grade dysplasia, RJ3, Radial Jaw 3, RJ4, Radial Jaw 4
To access this article, please choose from the options below
DISCLOSURE: The forceps for this investigation were provided by the Boston Scientific Corporation. The following author disclosed financial relationships relevant to this publication: S. Komanduri: Speaker for Boston Scientific; consultant for Tap Pharmaceuticals. All other authors disclosed no financial relationships relevant to this publication.
If you would like to chat with an author of this article, you may contact him at sri_komanduri@yahoo.com.
PII: S0016-5107(09)01728-3
doi:10.1016/j.gie.2009.04.009
© 2009 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
